E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/21/2018 in the Prospect News Emerging Markets Daily.

New Issue: India’s Piramal board OKs Rs. 5 billion of debentures due 2019, 2020

By Sarah Lizee

Olympia, Wash., Nov. 21 – Piramal Enterprises Ltd. notified the Bombay Stock Exchange that the administrative committee of its board of directors approved a private placement of Rs. 5 billion of 0% secured nonconvertible debentures in two series.

The Rs. 1 billion of series 1 debentures will have a tenor of 12 months.

The Rs. 4 billion of series 2 debentures will have a greenshoe of Rs. 5 billion and will have a tenor of 24 months.

Piramal Enterprises, formerly Piramal Healthcare Ltd., is a Mumbai-based subsidiary of the Piramal Group.

Issuer:Piramal Enterprises Ltd.
Issue:Secured nonconvertible debentures
Announcement date:Nov. 21
Distribution:Private placement
Series 1 debentures
Amount:Rs. 1 billion
Coupon:0%
Tenor:12 months
Series 2 debentures
Amount:Rs. 4 billion
Greenshoe:Rs. 5 billion
Coupon:0%
Tenor:24 months

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.